Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Care Therapy of Covid-19 Disease in Germany an Multi-center Observational Study

NCT04455451 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT04455451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04455451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Care Therapy of Covid-19 Disease in Germany an Multi-center Observational Study
Lead sponsor
University Hospital Tuebingen
Phase
Observational
Overall status
Completed
Start date
August 6, 2020
Completion date
September 30, 2021
Enrollment
2,054 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

ards, covid